Form 4: Dynavax Technologies Corp: Officer Metzinger Reports Stock Option and RSU Grant

Joseph Metzinger, VP and Chief Accounting Officer of Dynavax Technologies, reports the acquisition of stock options and restricted stock units (RSUs) on May 12, 2025.

Summary

• On May 12, 2025, Joseph Metzinger, VP, Chief Accounting Officer of Dynavax Technologies Corp, acquired stock options and Restricted Stock Units (RSUs).
• Metzinger acquired options for 31,500 shares of common stock at an exercise price of $9.85.
• These options vest over three years, with one-third vesting after twelve months and the remainder vesting monthly thereafter.
• He also acquired 38,182 RSUs, each representing a contingent right to receive one share of common stock.
• The RSUs vest over three years, with one-third vesting annually on each anniversary of May 12, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The grants themselves are neither overwhelmingly positive nor negative.

Positives

• The grant of stock options and RSUs to a key officer like the VP, Chief Accounting Officer, aligns their interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the officer.

Industry Context

Stock option and RSU grants are common forms of executive compensation in the biotechnology industry, used to incentivize performance and retain key personnel.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for executives in publicly traded companies, particularly in the biotech sector.
• The vesting schedules described (three-year vesting with annual or monthly tranches) are typical for such grants, aligning executive incentives with long-term company performance.
• Comparable companies in the biotech industry, such as Moderna (MRNA) and BioNTech (BNTX), also utilize stock options and RSUs as part of their executive compensation packages.

Stakeholder Impact

• The grants align management's interests with shareholders, potentially driving long-term value creation.
• Employees may view the grants as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

Dynavax Technologies, DVAX, Form 4, Stock Options, Restricted Stock Units, RSU, Insider Trading, Joseph Metzinger, Executive Compensation